This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
We’ve been there before. The movie “The Big Short” explains how and why the financial services industry helped to bring down our economy during 2007-08. Banks took home mortgage loans that were made based on shaky credit and pooled them into a basket of mortgage-backed securities (MBS) that were backed by the homes. These were Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
By Guest commentary / Friday, December 11th, 2015 / Op/Eds, Opinion / Comments Off on Corporate tax inversions unethical
You say you have a U.S. corporation and want to reduce corporate income taxes? Agree to be acquired by an Irish company and re-incorporate in Ireland. You’ll only pay 12.5 percent corporate income taxes rather than the 35 percent rate in the U.S. But wait. There’s more. Ireland recently announced that it reduced the rate Read More →
Universities aren’t always great at adapting to the workforce needs of today and tomorrow. Journalism schools across the land, for example, still churn out thousands of graduates every year — bright-eyed, but unable to find jobs, and soon forced to move back in with mom and start freelancing. But at Cal Poly San Luis Obispo, Read More →
Imagine you just went to your local pharmacy and were told that the cost of a life-saving drug was $22,500 for 30 tablets to treat AIDS or another infectious disease. Well, if you need the drug Daraprim, that is what you would have to pay. Turing Pharmaceuticals purchased the right to Darprim this past August Read More →